Psyence Biomedical Warrant
PBMWW
23 hedge funds and large institutions have $80.5K invested in Psyence Biomedical Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
46.98% more ownership
Funds ownership: 0% → 46.98% (+47%)
6% more capital invested
Capital invested by funds: $75.6K → $80.5K (+$4.85K)
18% less funds holding
Funds holding: 28 → 23 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$906 |
| 2 |
CS
Clear Street
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$3.5K |
| 2 |
FSI
Flow State Investments
Chicago,
Illinois
|
-$578 |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$525 |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$458 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1 |
PBMWW Hedge Fund Activity: Q3 2024 in Review
23 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q3 2024, worth a combined $80.5K — up 6.4% from $75.6K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PBMWW and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Cowen and Company, adding an estimated $906. The largest seller was LMR Partners, exiting entirely with an estimated $3.5K sold.
- 23 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q3 2024, down from 28 in Q2 2024.
- Funds reported $80.5K of Psyence Biomedical Warrant stock for Q3 2024, up 6.4% quarter-over-quarter.
- 0 funds opened new Psyence Biomedical Warrant positions in Q3 2024 and 5 closed out, a net change of -5 holders.
- The largest Psyence Biomedical Warrant buyer in Q3 2024 was Cowen and Company, an estimated $906 added.
- The largest Psyence Biomedical Warrant seller in Q3 2024 was LMR Partners, an estimated $3.5K sold.
Based on aggregated 13F filings for Q3 2024.